|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 52.52 USD | -2.43% |
|
-1.96% | +78.09% |
| 05/03 | Berenberg Raises Price Target on Moderna to $45 From $32, Keeps Hold Rating | MT |
| 05/03 | US stocks close up on Iran diplomacy hopes; tech leads rebound | RE |
Company Valuation: Moderna, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 1,02,976 | 69,006 | 37,919 | 16,001 | 11,523 | 20,742 | - | - |
| Change | - | -32.99% | -45.05% | -57.8% | -27.99% | 80.01% | - | - |
| Enterprise Value (EV) 1 | 92,848 | 59,104 | 29,315 | 8,976 | 5,724 | 16,877 | 18,298 | 18,695 |
| Change | - | -36.34% | -50.4% | -69.38% | -36.23% | 194.87% | 8.42% | 2.17% |
| P/E ratio | 8.98x | 8.93x | -8.07x | -4.48x | -4.06x | -7.57x | -11.5x | -18.2x |
| PBR | 7.24x | 3.7x | 2.74x | 1.46x | 1.33x | 3.09x | 4.18x | 5.59x |
| PEG | - | -0.3x | 0x | 0.2x | 0.2x | 1.72x | 0.3x | 0.5x |
| Capitalization / Revenue | 5.58x | 3.58x | 5.54x | 4.94x | 5.93x | 10x | 8.19x | 6.45x |
| EV / Revenue | 5.03x | 3.07x | 4.28x | 2.77x | 2.94x | 8.17x | 7.23x | 5.82x |
| EV / EBITDA | 6.86x | 6.05x | -8.1x | -2.39x | -2x | -6.07x | -10.3x | -19.6x |
| EV / EBIT | 6.98x | 6.27x | -6.92x | -2.28x | -1.86x | -5.9x | -9.28x | -15.6x |
| EV / FCF | 6.96x | 12.9x | -7.66x | -2.21x | -2.77x | -6.43x | -10.9x | -15x |
| FCF Yield | 14.4% | 7.75% | -13% | -45.2% | -36.1% | -15.5% | -9.16% | -6.66% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 28.29 | 20.12 | -12.33 | -9.28 | -7.26 | -6.941 | -4.562 | -2.88 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 18,471 | 19,263 | 6,848 | 3,236 | 1,944 | 2,067 | 2,532 | 3,214 |
| EBITDA 1 | 13,528 | 9,768 | -3,618 | -3,756 | -2,859 | -2,780 | -1,771 | -954.9 |
| EBIT 1 | 13,296 | 9,420 | -4,239 | -3,945 | -3,074 | -2,860 | -1,971 | -1,199 |
| Net income 1 | 12,202 | 8,362 | -4,714 | -3,561 | -2,822 | -2,738 | -1,817 | -1,164 |
| Net Debt 1 | -10,128 | -9,902 | -8,604 | -7,025 | -5,799 | -3,865 | -2,444 | -2,047 |
| Reference price 2 | 253.98 | 179.62 | 99.45 | 41.58 | 29.49 | 52.52 | 52.52 | 52.52 |
| Nbr of stocks (in thousands) | 4,05,450 | 3,84,180 | 3,81,284 | 3,84,818 | 3,90,734 | 3,94,939 | - | - |
| Announcement Date | 24/02/22 | 23/02/23 | 22/02/24 | 14/02/25 | 13/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.57x | 8.17x | -6.07x | -.--% | 2.07TCr | |
| 19.25x | 4.42x | 12.55x | 0.52% | 7.8TCr | |
| 27.55x | 5.47x | 15.8x | 0.58% | 5.54TCr | |
| 44.81x | 13.52x | 25.08x | -.--% | 5.12TCr | |
| 36.47x | 3.7x | 10.65x | 2.81% | 4.94TCr | |
| 15.62x | 2.88x | 8.36x | -.--% | 2.71TCr | |
| 15.08x | 2.43x | 7.68x | -.--% | 1.91TCr | |
| 74.02x | 8.75x | 87.5x | -.--% | 1.85TCr | |
| 633.76x | 4.95x | 12.67x | -.--% | 1.41TCr | |
| 284.59x | 95.55x | 173.96x | - | 1.34TCr | |
| Average | 114.36x | 14.98x | 34.82x | 0.43% | 3.47TCr | |
| Weighted average by Cap. | 62.92x | 9.60x | 23.18x | 0.63% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- MRNA Stock
- Valuation Moderna, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition